BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21965756)

  • 21. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
    Gao GL; Liu LD; Zou XS; Chen WX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.
    Rauvala M; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
    Ishida H; Murata N; Tada M; Okada N; Hashimoto D; Kubota S; Shirakawa K; Wakasugi H
    Jpn J Clin Oncol; 2003 Apr; 33(4):186-91. PubMed ID: 12810833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
    Li O; Yi W; Yang P; Guo C; Peng C
    Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
    Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
    Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
    Będkowska GE; Gacuta E; Zajkowska M; Głażewska EK; Osada J; Szmitkowski M; Chrostek L; Dąbrowska M; Ławicki S
    J Ovarian Res; 2017 Jun; 10(1):39. PubMed ID: 28662671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CA125 and HE4: Measurement Tools for Ovarian Cancer.
    Zhao T; Hu W
    Gynecol Obstet Invest; 2016; 81(5):430-5. PubMed ID: 27160726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
    Pang L; Wang DW; Zhang N; Xu DH; Meng XW
    Cancer Biomark; 2016 Mar; 16(4):599-607. PubMed ID: 27002762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
    Obayashi Y; Yabushita H; Kanyama K; Noguchi M; Zhuo L; Kimata K; Wakatsuki A
    Oncol Rep; 2008 May; 19(5):1245-51. PubMed ID: 18425383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
    Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
    World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J; Hu J; Liu G; Cui Y; Ju Y
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma.
    Tan SY; Wang JY; Shen L; Luo HS; Shen ZX
    World J Gastroenterol; 2007 Apr; 13(14):2108-12. PubMed ID: 17465457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.